{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-159193","form_type":"8-K","ticker":"IOBTQ","cik":"0001865494","company_name":"IO Biotech, Inc.","filed_at":"2024-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.973477+00:00","generated_at":"2026-06-01T05:08:26.398482+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"IO Biotech stockholders elect three directors and ratify EY as auditor at 2024 annual meeting","bullets":["Kathleen Sereda Glaub, Peter Hirth, and Mai-Britt Zocca elected as Class III directors until 2027.","Votes for each director exceeded 42 million; broker non-votes 3.9 million on each.","Ratification of EY as independent auditor for FY 2024 approved with 47.2 million for, 67k against.","No other matters were voted on at the June 6, 2024 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-159193","json":"https://secwatch.observer/filing/0001193125-24-159193.json","markdown":"https://secwatch.observer/filing/0001193125-24-159193.md","text":"https://secwatch.observer/filing/0001193125-24-159193.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1865494/000119312524159193/0001193125-24-159193-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1865494/000119312524159193/d768244d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:08:26.398482+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}